Quest Diagnostics Inc Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Quest Diagnostics Inc stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $17.00M, a 30.77% increase year-over-year.
- Quest Diagnostics Inc stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $65.00M, a 124.14% increase year-over-year.
- Quest Diagnostics Inc stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $14.00M, a 33.33% decline year-over-year.
- Quest Diagnostics Inc stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $23.00M, a 4.17% decline year-over-year.
- Quest Diagnostics Inc stock issued during period, value, stock options exercised for fiscal 2025 was $79.00M, a 8.22% increase from fiscal 2024.
- Quest Diagnostics Inc stock issued during period, value, stock options exercised for fiscal 2024 was $73.00M, a 1.39% increase from fiscal 2023.
- Quest Diagnostics Inc stock issued during period, value, stock options exercised for fiscal 2023 was $72.00M, a 41.46% decline from fiscal 2022.
- Quest Diagnostics Inc stock issued during period, value, stock options exercised for fiscal 2022 was $123.00M, a 4.65% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $17.00M 10-Q · filed 2026-07-23 | $119.00M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $65.00M 10-Q · filed 2026-04-22 | $115.00M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $14.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $79.00M 10-K · filed 2026-02-26 |
| 2025-09-30 | $23.00M 10-Q · filed 2025-10-21 | $86.00M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $13.00M 10-Q · filed 2026-07-23 | $87.00M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $29.00M 10-Q · filed 2026-04-22 | $90.00M derived: sum of 4 quarters · filed 2026-04-22 |
| 2024-12-31 | $21.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $73.00M 10-K · filed 2026-02-26 |
| 2024-09-30 | $24.00M 10-Q · filed 2025-10-21 | $64.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $16.00M 10-Q · filed 2025-07-23 | $52.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $12.00M 10-Q · filed 2025-04-23 | $54.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $72.00M 10-K · filed 2026-02-26 |
| 2023-09-30 | $12.00M 10-Q · filed 2024-10-23 | $87.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $18.00M 10-Q · filed 2024-07-24 | $103.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $30.00M 10-Q · filed 2024-04-24 | $143.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $27.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $123.00M 10-K · filed 2025-02-20 |
| 2022-09-30 | $28.00M 10-Q · filed 2023-10-25 | $117.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $58.00M 10-Q · filed 2023-07-27 | $129.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $10.00M 10-Q · filed 2023-04-28 | $122.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $21.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $129.00M 10-K · filed 2024-02-22 |
| 2021-09-30 | $40.00M 10-Q · filed 2022-10-21 | $153.00M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $51.00M 10-Q · filed 2022-07-22 | $140.00M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $17.00M 10-Q · filed 2022-04-22 | $126.00M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $45.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $189.00M 10-K · filed 2023-02-21 |
| 2020-09-30 | $27.00M 10-Q · filed 2021-10-22 | $165.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $37.00M 10-Q · filed 2021-07-23 | $170.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $80.00M 10-Q · filed 2021-04-23 | $179.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $21.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $119.00M 10-K · filed 2022-02-28 |
| 2019-09-30 | $32.00M 10-Q · filed 2020-10-23 | $102.00M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $46.00M 10-Q · filed 2020-07-24 | $94.00M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $20.00M 10-Q · filed 2020-05-04 | $85.00M derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $99.00M 10-K · filed 2021-02-22 |
| 2018-09-30 | $24.00M 10-Q · filed 2019-10-23 | $100.00M derived: sum of 4 quarters · filed 2020-02-20 |
| 2018-06-30 | $37.00M 10-Q · filed 2019-07-24 | $104.00M derived: sum of 4 quarters · filed 2020-02-20 |
| 2018-03-31 | $34.00M 10-Q · filed 2019-04-24 | $118.00M derived: sum of 4 quarters · filed 2020-02-20 |
| 2017-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $130.00M 10-K · filed 2020-02-20 |
| 2017-09-30 | $28.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-24 | $135.00M derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-06-30 | $51.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-25 | $132.00M derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-03-31 | $46.00M 10-Q · filed 2018-04-20 | $112.00M derived: sum of 4 quarters · filed 2019-02-21 |
| 2016-12-31 | $10.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $73.00M 10-K · filed 2019-02-21 |
| 2016-09-30 | $25.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-19 | $65.00M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | $31.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | $43.00M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | $7.00M 10-Q · filed 2017-04-21 | $32.00M derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $60.00M 10-K · filed 2018-02-23 |
| 2015-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-21 | $81.00M derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-06-30 | $20.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-25 | $103.00M derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-03-31 | $35.00M 10-Q · filed 2016-04-27 | $101.00M derived: sum of 4 quarters · filed 2017-02-22 |
| 2014-12-31 | $23.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $78.00M 10-K · filed 2017-02-22 |
| 2014-09-30 | $25.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $95.00M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $18.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $105.00M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $12.00M 10-Q · filed 2015-04-30 | $136.00M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $40.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $138.00M 10-K · filed 2016-02-26 |
| 2013-09-30 | $35.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $116.06M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $49.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $134.42M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $14.00M 10-Q · filed 2014-05-01 | $111.60M derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $18.05M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $162.00M 10-K · filed 2015-02-24 |
| 2012-09-30 | $53.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-24 | $176.94M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-06-30 | $26.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | $130.36M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-03-31 | $64.40M 10-Q · filed 2013-04-24 | $147.61M derived: sum of 4 quarters · filed 2014-02-18 |
| 2011-12-31 | $33.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $137.00M 10-K · filed 2014-02-18 |
| 2011-09-30 | $6.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $111.75M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $43.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | $105.58M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $53.79M 10-Q · filed 2012-04-27 | $82.58M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $7.75M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $48.53M 10-K · filed 2013-02-27 |
| 2010-09-30 | $613.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $81.33M derived: sum of 4 quarters · filed 2012-02-16 |
| 2010-06-30 | $20.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-27 | $110.07M derived: sum of 4 quarters · filed 2012-02-16 |
| 2010-03-31 | $19.74M 10-Q · filed 2011-05-10 | |
| 2009-12-31 | $40.54M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-16 | $87.12M 10-K · filed 2012-02-16 |
| 2009-09-30 | $29.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | |
| 2008-12-31 | $30.51M 10-K · filed 2011-02-16 | |
| 2007-12-31 | $80.93M 10-K · filed 2010-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |